Purpose

Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past research, the researchers are doing this study to find out whether telehealth music therapy is a practical treatment for cognitive difficulties in blood cancer survivors. The researchers will also study whether music therapy and music education help improve cognitive function and other common symptoms such as anxiety, depression, and/or tiredness.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • English-proficient, aged 18 or older - Diagnosis of lymphoma, leukemia, or myeloma - Stable oncologic disease or no evidence of disease as indicated in the medical chart or by the oncology team - Score of <54 on the FACT-Cog PCI subscale - Minimum life expectancy of one year as per clinician assessment - Patient should be able to understand and complete all study assessments on their own. - Eligible patient should be able to understand informed consent and provide signed informed consent in English.

Exclusion Criteria

  • Less than 3 months since completion of surgery, radiation, induction chemotherapy (for newly diagnosed or relapsed disease), transplantation, or immunotherapy (e.g., CAR T-Cell, bispecific antibodies) - If there is a defined treatment period, the patient must be at least 3 months from treatment completion - If the patient is on continuous therapy, patient must have completed at least 6 months of the therapy - Maintenance therapies are allowed - Received music therapy (MT) in the past year - Current music training, >6 months of music training in the past 10 years, or plan to initiate music training during the study - No access to an internet-connected device - Active suicidal ideation, bipolar, schizophrenia, or substance abuse - BOMC score ≥10 (indicative of dementia) - Uncorrectable visual, auditory, or motor impairments - Initiation or altered dose of sedative, stimulant, or anti-cholinergic medications in the past month or plan to initiate these medications during the study, as these are known to impact cognitive function - Initiation of any other interventions for CRCD (e.g., cognitive rehabilitation) in the past month or plan to initiate these interventions during the study, as these are known to impact cognitive function

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Music Therapy/MT
Participants will receive 12, weekly 60-minute MT sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts, practice musical skills, and serve as transitions to subsequent sessions
  • Other: Music Therapy/MT
    Therapeutic music lessons are the core component of the Music Therapy/MT intervention. Other components include guided music listening to help participants use music as a tool for regulating mood, energy, and attention, as well as music-centered discussions to help participants discover songs with personal meaning that they will enjoy learning to play.
Active Comparator
Therapist Attention-Music Education/TAME control
Patients will receive 12, weekly 60-minute Therapist Attention-Music Education/TAME sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts and serve as transitions to subsequent sessions. The TAME control group will involve board-certified music therapists guiding participants through music listening exercises.
  • Other: Therapist-Attention Music Education/TAME Control
    Participants will receive 12, weekly 60-minute TAME sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts and serve as transitions to subsequent sessions. The TAME control group will involve board-certified music therapists guiding participants through music listening exercises.
No Intervention
Wait-List Control/WLC
The Wait-List Control/WLC group will receive usual care from healthcare providers and complete the same assessments as the other groups. The WLC will have the option of receiving either 12 sessions of MT or 12 sessions of TAME intervention when the study concludes after the 24-week waiting period. The WLC participants will choose which intervention (MT or TAME) they wish to receive.

Recruiting Locations

Memorial Sloan Kettering Basking Ridge (All protocol activities)
Basking Ridge, New Jersey 07920
Contact:
Kevin Liou, MD
646-608-8559

Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown, New Jersey 07748
Contact:
Kevin Liou, MD
646-608-8559

Memorial Sloan Kettering Bergen (All protocol activities)
Montvale, New Jersey 07645
Contact:
Kevin Liou, MD
646-608-8559

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities)
Commack, New York 11725
Contact:
Kevin Liou, MD
646-608-8559

Memorial Sloan Kettering Westchester (All protocol activities)
Harrison, New York 10604
Contact:
Kevin Liou, MD
646-608-8559

Memorial Sloan Kettering Cancer Center (All protocol activities)
New York, New York 10065
Contact:
Kevin Liou, MD
646-608-8563

Memorial Sloan Kettering Nassau (All protocol activities)
Uniondale, New York 11553
Contact:
Kevin Liou, MD
646-608-8559

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Kevin Liou, MD
646-608-8563
liouk@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.